Fibrocell Science, Inc. To Present At Barclays Global Healthcare Conference 2014
3/6/2014 7:19:20 AM
Fibrocell Science (NYSEMKT:FCSC), an autologous cell therapy company primarily focused on developing first-in-class treatments for skin diseases and conditions with high unmet medical needs, today announced that David Pernock, chairman and chief executive officer of Fibrocell Science, will present at the Barclays Global Healthcare Conference 2014 at 2:30 pm EDT on Wednesday, March 12, 2014, at the Loews Hotel in Miami.
Help employers find you! Check out all the jobs and post your resume.
comments powered by